Estrogen agonist/antagonist metabolites

Details for Australian Patent Application No. 2001240985 (hide)

Owner Pfizer Products Inc.

Inventors Eggler, James Frederick; Prakash, Chandra Aggarwal; Johnson, Kim Anne; Day, Wesley Warren

Agent Spruson & Ferguson

Pub. Number AU-B-2001240985

PCT Pub. Number WO01/77093

Priority 60267198 07.04.00 US

Filing date 19 March 2001

Wipo publication date 23 October 2001

Acceptance publication date 4 August 2005

International Classifications

C07D 295/08 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 031/195

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

C07C 229/12 Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07D 207/26 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

4 August 2005 Application Accepted

  Published as AU-B-2001240985

1 December 2005 Standard Patent Sealed

2 November 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001240986

2001240983